- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tela Bio Inc (TELA)
Tela Bio Inc stock price live, this page displays NASDAQ TELA stock exchange data. View the TELA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tela Bio Inc real time stock price chart below.
What Is the Tela Bio Inc Stock Price Today?
The Tela Bio Inc stock price today is 0.822.
What Is the Stock Symbol for Tela Bio Inc?
The stock symbol for Tela Bio Inc is "TELA."
What Stock Exchange Does Tela Bio Inc Trade On?
Tela Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Tela Bio Inc a Good Stock to Buy?
Determining whether Tela Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TELA quote. (ISIN: US8723811084)
What Is the Tela Bio Inc Stock Price Today?
The Tela Bio Inc stock price today is 0.822.
What Is the Stock Symbol for Tela Bio Inc?
The stock symbol for Tela Bio Inc is "TELA."
What Stock Exchange Does Tela Bio Inc Trade On?
Tela Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Tela Bio Inc a Good Stock to Buy?
Determining whether Tela Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TELA quote. (ISIN: US8723811084)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.790
0.843
52 wk Range
0.501
1.727
TELA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7900.843
52 wk Range
0.5011.727
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TELA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
2.100
Upside
+155.47%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- TELA Bio cuts costs by $17M and replaces COO/CFO
- Investing.com
- TELA Bio cuts costs by $17M and replaces COO/CFO
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2.100
(+155.47% Upside)
Tela Bio Inc SWOT Analysis
Biologic Innovation | Explore TELA Bio's pioneering OviTex mesh for hernia repair, offering biocompatibility and cost-effectiveness over traditional plastic alternatives |
Market Dynamics | Delve into TELA Bio's position amidst the industry shift from plastic to biologic mesh, and its potential for significant market share gains |
Financial Outlook | Learn about TELA Bio's revenue projections, with analyst estimates ranging from $105.5 million to $115 million for 2026, despite current profitability challenges |
Strategic Challenges | Uncover TELA Bio's response to aggressive competitor tactics, including sales force refinements and a $5-10 million cost reduction plan for 2025 |
Tela Bio Inc Earnings Call Summary for Q2/2026
- TELA Bio Q2 revenue of $19.3M missed estimates by 8.3%; EPS loss of $0.20 missed by 17.7%; company withdrew full-year 2026 guidance.
- PRS revenue plunged 24.7% to $5.5M due to sales pilot confusion and surgeon availability; OviTex hernia unit volume grew 12% year-over-year.
- Gross margin improved to 72% from 70% on tariff refunds; management plans cost cuts to align spending with sales and extend $30.4M cash runway.
- Company expects H2 2026 PRS recovery with seasonal strength; projects Q3 revenue of $22.8M, Q4 at $25M, and FY2027 revenue of $95.5M.
- CEO cited anti-competitive bundling by larger rivals as barrier; fewer than 10 PRS sites drove decline; new sales reps now need 9-12 months to ramp.
Last Updated: 2026-08-10, 05:16 p/m
Read Full TranscriptEarnings
Latest Release
Aug 10, 2026
EPS / Forecast
-0.20 / -0.17
Revenue / Forecast
19.3M / 21.04M
Compare TELA to Peers and Sector
Metrics to compare | TELA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTELAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −2.2x | −0.4x | |
PEG Ratio | −0.03 | −0.09 | 0.00 | |
Price/Book | −2.3x | 2.3x | 2.6x | |
Price / LTM Sales | 0.5x | 2.2x | 3.0x | |
Upside (Analyst Target) | 143.3% | 21.5% | 47.5% | |
Fair Value Upside | Unlock | 8.4% | 6.7% | Unlock |
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Tela Bio (TELA) Stock Price Today?
The Tela Bio stock price today is 0.822 USD.
What Stock Exchange Does Tela Bio Trade On?
Tela Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Tela Bio?
The stock symbol for Tela Bio is "TELA."
What Is the Tela Bio Market Cap?
As of today, Tela Bio market cap is 37.090M USD.
What Is Tela Bio's Earnings Per Share (TTM)?
The Tela Bio EPS (TTM) is -0.778.
When Is the Next Tela Bio Earnings Date?
Tela Bio will release its next earnings report on Nov 11, 2026.
From a Technical Analysis Perspective, Is TELA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Tela Bio Stock Split?
Tela Bio has split 0 times.
How Many Employees Does Tela Bio Have?
Tela Bio has 218 employees.
What is the current trading status of Tela Bio (TELA)?
As of Sep 07, 2026, Tela Bio (TELA) is trading at a price of 0.822 USD, with a previous close of 0.781 USD. The stock has fluctuated within a day range of 0.790 USD to 0.843 USD, while its 52-week range spans from 0.501 USD to 1.727 USD.
What Is Tela Bio (TELA) Price Target According to Analysts?
The average 12-month price target for Tela Bio is 2.100 USD, with a high estimate of 3 USD and a low estimate of 1 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +155.47% Upside potential.
What Is the TELA After Hours Price?
TELA's last after hours stock price is 0.830 USD, the stock has decreased by 0.009, or 1.050%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.